Clinical trial
Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs…
NCT00283790 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00283790 |
|---|---|
| Title | Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo |
| Official title | Investigation of Psycliomotor and Cognitive Residual Effects After Single Oral Doses of Zolpidem Tartrate Extended Release 12.5 mg and Eszopielone 3 mg Compared to Placebo in Healthy Young Volunteers, Using Plurazepam 30 mg As An External Comparator |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Insomnia |
| Intervention type | Drug |
| Interventions | zolpidem tartrate |
| Enrollment | 36 |
| Start date | Jan 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Jan 30, 2006 |
| Last update posted | Apr 3, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: